Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: An unusual pathogen with unusual multidrug resistance

Pharmacotherapy

Volumn 26, Issue 11, 2006, Pages 1646-1649

  Kang Birken, S Lena ^a,b,c   Prichard, John G ^a  

^a VENTURA COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

^c Department of Pharmacy Services   (United States)

Author keywords

AIDS; Multidrug resistance; Mycobacteriurn szulgai; Nontuberculosis

Indexed keywords

AMIKACIN; ANTIMYCOBACTERIAL AGENT; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; EFAVIRENZ; ETHAMBUTOL; IMIPENEM; INDINAVIR; ISONIAZID; PRIMAQUINE; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; COUGHING; DYSPNEA; FEVER; HUMAN; LUNG DISEASE; LUNG INFILTRATE; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM SZULGAI; NIGHT SWEAT; SPUTUM ANALYSIS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HIV-1; HUMANS; MALE; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL;

EID: 33750704642     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.11.1646     Document Type: Article

References (21)

1. Maloney JM, Gregg CR, Stephens DS, et al. Infections caused by Mycobacterium szulgai in humans. Rev Infect Dis 1987;9:1120-6.
2. Benator DA, Kan V, Gordin FM. Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen. Am J Med Sci 1997;313:346-51.
3. Dylewski JS, Zackon HM, Latour AH, Berry GR. Mycobacterium szulgai: an unusual pathogen. Rev Infect Dis 1987;9:578-80.
4. Pocza A. Pulmonary infection caused by Mycobacterium szulgai. Med J Aust 1981;1:419-20.
5. Gur H, Porat S, Haas H, Naparstek Y, Eliakim M. Disseminated mycobacterial disease caused by Mycobacterium szulgai. Arch Intern Med 1984;144:1861-3.
6. Frisk P, Boman G, Pauksen K, et al. Skin infection caused by Mycobacterium szulgai after allogeneic bone marrow transplantation: case report. Bone Marrow Transplant 2003;31:511-13.
7. Frueh BE, Dubuis O, Imesch P. Mycobacterium szulgai keratitis. Arch Ophthalmol 2000;118:1123-4.
8. Hakawi AM, Alraihi AA. Septic arthritis due to Mycobacterium szulgai in a patient with human immunodeficiency virus: case report. Scand J Infect Dis 2005;37:235-7.
9. Fang CT, Chang SC, Luh KT, et al. Successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol. J Infect Dis 1999;38:195-204.
10. Cross GM, Guill MA, Aton JK. Cutaneous Mycobacterium szulgai infection. Arch Dematol 1985;121:247-9.
11. Newshan G, Torres RA. Pulmonary infection due to multidrug-resistant Mycobacterium szulgai in a patient with AIDS. Clin Infect Dis 1994;18:1022-3.
12. Luque AE, Kaminski D, Reichman R, Hardy D. Mycobacterium szulgai osteomyelitis in an AIDS patient. Scand J infect Dis 1998;30:88-91.
13. Tappe D, Langmann P, Zilly M, et al. Osteomyelitis and skin ulcers caused by Mycobacterium szulgai in an AIDS patient. Scand J Infect Dis 2004;36:883-5.
14. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:51-25.
15. Good RC, Silcox VA, Kilburn JD, Plikaytis BD. Identification and drug susceptibility test results for Mycobacterium spp. Clin Microbiol Newsl 1985;7:133-5.
16. Haas H, Michel J, Sacks TG. In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin. Chemotherapy 1982;28:1-5.
17. Brown BA, Wallace RJ Jr, Onyi GO. Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. Antimicrob Agents Chemother 1992;36:1987-90.
18. Rastogi N, Goh KS, Bryskier A, Devallois A. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine. Antimicrob Agents Chemother 1996;40:2483-7.
19. Nakayama S, Fujii T, Kadota J, et al. Pulmonary mycobacteriosis caused by rifampicin-resistant Mycobacterium szulgai. Intern Med 2000;39:309-12.
20. Abalain-Colloc ML, Guillerm D, Salaun M, et al. Mycobacterium szulgai isolated from a patient, a tropical fish and aquarium water. Eur J Clin Microbiol Infect Dis 2003;22:768-9.
21. Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. Clin infect Dis 2005;40:5131-235.